Navigation Links
Biomatrica Secures Strategic Investment from IQT
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Biomatrica, Inc., a leader in room temperature biostability technology, today announced a strategic partnership agreement with In-Q-Tel (IQT). IQT is the independent, strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community.

Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples from purified DNA, RNA, and proteins as well as in complex systems such as tissue, cell lines, biopsies and whole blood. The company's products serve a wide range of customers such as those in the forensics, biomedical research (academic, government and industry), molecular diagnostics and biobanking. Biomatrica was recently recognized as a Finalist for the Most Innovative New Product Award (MIP) in the Life Science and Diagnostics category as conducted by San Diego's CONNECT.

"Biomatrica's technology capability is an important addition to our strategic investment portfolio," said Syd Ulvick, Vice President, Physical and Biological Technologies Practice at IQT. "The company's technology advances offer great promise for applications in both the government and commercial sector."

"As the needs of research and medicine to manage biological samples grow, increasing energy and environmental cost associated with cold storage of biological samples, it is critical for biobanks, research institutions and biotechnology companies to identify alternative storage solutions," said Judy Muller-Cohn, Ph.D., CEO and co-founder of Biomatrica. "The SampleMatrix technology allows for safe, long term preservation of biological samples at room temperature. Sample recovery is simple and sample integrity is assured."

SampleMatrix® is based on extremophile biology in which organisms are able to survive long-term in a state of anhydrobiosis (life without water) and later be revived by rehydration. Extremophiles such as tardigrades, also known as water bears, and brine shrimp are able protect their DNA, RNA, proteins, membranes and cellular systems in a dried state for extended periods of time. Biomatrica's technology mimics the natural molecular mechanisms used by these organisms. The technology works by forming a thermo-stable barrier during the drying process to protect samples from degradation during storage at room temperature.

About Biomatrica®, Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing and shipping biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA, RNA, proteins, cells and assays with no sample degradation, allowing scientists and clinicians to have pristine samples and reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this technology platform (DNAstable®, DNAstable Blood, DNAgard Tissue and DNAgard Blood for DNA, RNAstable® and RNAconcentrator for RNA, and CloneStable® for bacterial DNA), visit: www.biomatrica.com.

About IQT

In-Q-Tel is the strategic, not-for-profit investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the U.S. Intelligence Community. Launched in 1999 as a private, independent organization, IQT's mission is to identify and partner with companies developing cutting-edge technologies that serve the national security interests of the United States. Working from an evolving strategic blueprint defining the Intelligence Community's critical technology needs, IQT engages with entrepreneurs, growth companies, researchers, and investors to deliver technologies that provide superior capabilities for the CIA and the larger Intelligence Community. To learn more about IQT, visit www.iqt.org.


'/>"/>
SOURCE Biomatrica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
2. Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
3. Digital Assent Secures $2 Million Series A Financing to Grow PatientPad Point-of-Care Network
4. TechniScan Secures $10 Million Equity Financing Facility
5. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
6. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
7. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
8. Sutro Biopharma Secures $36.5 Million in Series C Financing
9. K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
10. Unilife Secures U.S. Government Financial Backing for the Completion of New Global Headquarters and Manufacturing Facility in York, PA
11. Prolong Pharmaceuticals Secures $30 Million in Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... SAN DIEGO , June 23, 2016 /PRNewswire/ ... advancing programs that address medical conditions resulting from ... that it has appointed Greg Doyle ... member of Leading BioSciences, executive management team and ... officer and chief financial officer. He will provide ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):